SPIRO-CONDENSED INDOLE COMPOUNDS AS EHMT2 INHIBITORS
申请人:Epizyme Inc
公开号:EP4105203A1
公开(公告)日:2022-12-21
The present disclosure relates to substituted fused bi- or tri- heterocyclic compounds of formula (Va) to (Vf). The present disclosure also relates to pharmaceutical compositions containing these compounds. Said compounds are for use in methods of treating a disorder (e.g., sickle cell anemia) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2.